Contrast induced nephropathy in older Vietnamese patients undergoing coronary angiography and intervention
نویسندگان
چکیده
Abstract Funding Acknowledgements Type of funding sources: None. Background The prevalence coronary heart disease increases with age and older people accounted for a large proportion patients presenting disease. Advancement in percutaneous intervention (PCI) has contributed to reduced mortality artery However, angiography have also increased the risk developing contrast induced nephropathy (CIN), especially patients. More than ten assessment tools been developed predict CIN. Among these, Mehran score most commonly used Vietnam. In recent years, new simple prediction models proposed, including volume-to-glomerular filtration rate ratio (CV/GFR ratio). CV/GFR is calculated as medium quantity glomerular rate. Purpose aim this study was (1) examine incidence CIN cohort undergoing and/or PCI at tertiary hospital Vietnam, (2) compare validity predicting CIN, (3) identify optimal cut-off points these scales by which can help high population. Methods A prospective observational conducted aged ≥ 60 years Vietnam from September 2019 May 2020. defined 25% increase serum creatinine baseline or 0.5mg/dL absolute occurring within 48 hours post IV administration. were applied Previous studies suggest >5 >3.7 predictor an early abnormal after PCI. Receiver Operator Characteristic (ROC) evaluate area under curve (AUC) sensitivity, specificity common that suggested previous studies. Results total 170 participants included study. They had mean 70 33.1% women. 9.4%. Participants higher chronic kidney disease, failure anaemia admission. AUC against 0.79 (95%CI 0.65-0.92), 0.65 0.51-0.82) (Figure 1). sensitivity are presented Figure 2. Conclusions Our found Both good diagnostic value participants.
منابع مشابه
Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
BACKGROUND Contrast media are being widely applied for both diagnostic and therapeutic purposes. This has resulted in increasing incidence of contrast-induced nephropathy (CIN). METHODS We aimed to investigate the value of baseline serum IL-6 concentrations in predicting CIN before the rise of serum creatinine (SCr) in patients undergoing percutaneous coronary intervention. Seventy four Cauca...
متن کاملIloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
BACKGROUND The prevention of contrast-induced nephropathy, which accounts for considerable morbidity and mortality, remains a vexing problem. Contrast-induced renal vasoconstriction is believed to play a pivotal role in the pathogenesis of contrast-induced nephropathy. The aim of this study was to examine the efficacy of the prostacyclin analog iloprost in preventing contrast-induced nephropath...
متن کاملAscorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
BACKGROUND Contrast agents can cause a reduction in renal function that may be due to the generation of reactive oxygen species. Conflicting evidence suggests that administration of the antioxidant acetylcysteine prevents this renal impairment. The action of other antioxidant agents has not been investigated. METHODS AND RESULTS We conducted a randomized, double-blind, placebo-controlled tria...
متن کاملContrast Induced Nephropathy After Brain and Cervical CT Angiography in Stroke Patients: A Prospective Study
Background: Contrast-induced nephropathy (CIN) is a major side effect of intravenous iodinated contrast and causes both short- and long-term adverse effects. While diagnostic and interventional procedures of brain ischemia are recently advanced, it is necessary to be cautious about its major side effect. Objectives: To evaluate CIN and its risk factors in neurology patients after brain and cer...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2023
ISSN: ['2634-3916']
DOI: https://doi.org/10.1093/eurheartj/ehac779.114